Brookfield Business (BBUC) Q2 2026 earnings review
Asset Recycling Obscures Top-Line Contraction, but Underlying Margins Hold Firm
Brookfield Business Corporation (BBUC) continues to function less like a traditional operating company and more like a publicly traded private equity fund. Headline revenue contracted 3% YoY to $6.49B, and Adjusted EBITDA was flat at $587M. However, this optical stagnation masks a highly active portfolio rotation. Management generated $1.2B in capital recycling year-to-date—highlighted by the $650M sale of legacy asset Multiplex—and deployed $315M into new, mission-critical service acquisitions (World Freight Company, Gregg Distributors). Excluding dispositions, same-store EBITDA grew 5%, proving that underlying cash generation remains stable even as the portfolio shrinks to fund massive share buybacks.
🐂 Bull Case
BBUC is aggressively monetizing mature assets (Multiplex, Altera FPSO, La Trobe) and funneling proceeds into buybacks at a ~50% discount to NAV, retiring $300M+ in shares since early 2025. This mechanically drives up intrinsic value per share.
The Industrials segment is accelerating. Clarios (advanced energy storage) alone generated enough cash to repay $500M in debt this quarter, while maintaining a multi-billion-dollar US investment program.
🐻 Bear Case
While aggregate numbers look stable, specific assets are showing cracks. Sagen's (mortgage insurance) loss ratios are climbing, CDK faces elevated churn and distressed debt chatter, and Infrastructure Services saw a 12% EBITDA drop.
Continually selling large revenue-generating assets creates a permanent headwind to headline growth. Unless new acquisitions (World Freight, Gregg) scale rapidly, top-line contraction will persist.
⚖️ Verdict: ⚪
Neutral to slightly Bullish. The reported financials look stagnant, but the aggressive and highly accretive share buyback program, funded by disciplined asset sales, makes this a compelling value-compounding story.
Key Themes
Capital Recycling Engine is Accelerating
BBUC's primary value driver is its capital rotation strategy. Management has already hit $1.2B in YTD proceeds, tracking well ahead of its $2B / 24-month target. The Q2 sale of Multiplex ($650M) removes a legacy, low-margin construction asset. Proceeds are being immediately recycled into higher-margin, asset-light essential services (World Freight Company for $175M; Gregg Distributors for $140M) and deeply discounted share repurchases.
Industrials Segment Leading the Charge
Industrials remains the strongest pillar, with Adjusted EBITDA growing 6% on a same-store basis to $323M. Clarios is driving the bus, capitalizing on a shift to higher-margin advanced batteries. Furthermore, DexKo effectively optimized costs to expand margins despite soft end-market volumes, extending its debt maturities by 3 years to weather the macro environment.
DeployCo and Tangible AI Implementation
Management closed its $100M strategic investment into OpenAI's 'DeployCo' and is already demonstrating tangible ROI. Rather than generic 'AI' buzzwords, BBUC is executing specific industrial use cases: Chemelex is using AI polymer blending models based on ambient plant conditions to reduce yield loss, and Clarios installed machine learning sensors to optimize maintenance schedules and inventory. This operational leverage is structurally improving margins.
Infrastructure Services Reversing Trend
Infrastructure Services was the clear laggard, with Adjusted EBITDA decelerating sharply, down 12% YoY from $109M to $96M. Management attributed this to a contract penalty at a lottery services joint venture and elevated investment spend. While positioned as temporary, this broke the segment's stable earnings trajectory and requires monitoring.
Mortgage Insurer (Sagen) Loss Ratios Ticking Up
Sagen's loss ratio increased to 17% in the quarter. While management frames this as a 'normalization' back to historical 15-25% ranges, the underlying macro driver is concerning: home price depreciation in Canada is eroding homeowner equity, leading to lower cure rates on delinquent mortgages. The addressable market is growing due to 30-year amortizations, but the risk profile is undeniably worsening.
CDK Global Debt and Churn Pressures
A stark contradiction emerged regarding CDK. Management touted 'resilient performance' supported by price increases and cost optimization. However, analysts pointed out that CDK's debt is trading at distressed levels, faces a negative credit watch, and is suffering from elevated customer churn. Management dismissed media reports and defended CDK's positive operating cash flow, but the distress in the capital structure suggests significant underlying operational friction.
Other KPIs
Up from $1.9 billion on the balance sheet at quarter-end, adjusting for announced but unclosed transactions (Multiplex sale, WFC/Gregg acquisitions). This provides massive firepower for further M&A or expanded buybacks.
BBUC continues to aggressively retire shares. YTD, the company has allocated over $320M to buybacks (including an additional $150M earmarked from recent sales), continually executed at roughly a 50% discount to intrinsic value.
Guidance
Management stated they have achieved $1.2B of this target in less than one year. With the IPO market improving and several large assets (like BRK Ambiental) held in reserve, the pace is accelerating.
Expected to close in 26Q4. This will trigger a significant cash influx, with roughly $530M expected in cash at closing plus an earn-out.
Expected to close in 26Q3. This secures a 25% interest in an asset-light, high-cash-conversion logistics business ripe for AI-driven back-office consolidation.
Key Questions
CDK Capital Structure Viability
Given the distressed trading levels of CDK's debt and the elevated churn, at what point does the current capital structure become unsustainable, and will Brookfield need to inject fresh equity to defend the asset?
Lottery Services Contract Penalty
Can you quantify the exact financial impact of the contract penalty at the lottery joint venture in Q2, and is this a one-time true-up or indicative of ongoing performance failures?
Sagen Cure Rate Trajectory
With Sagen's loss ratios hitting 17% due to lower cure rates from depleted home equity, what happens to profitability if Canadian home prices decline another 5-10% and push loss ratios beyond your normalized 25% upper bound?
Limits of the Buyback Strategy
You are aggressively shrinking the equity base at a 50% discount to NAV. At what target float or liquidity threshold does the buyback strategy begin to negatively impact the stock's tradability?